创新医疗
(002173)
| 流通市值：75.29亿 | | | 总市值：78.95亿 |
| 流通股本：4.21亿 | | | 总股本：4.41亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 337,763,261.5 | 166,663,239.83 | 781,251,044.68 | 597,495,213.85 |
| 营业收入 | 337,763,261.5 | 166,663,239.83 | 781,251,044.68 | 597,495,213.85 |
| 二、营业总成本 | 394,716,441.55 | 192,751,923.47 | 852,868,865.07 | 628,500,075.15 |
| 营业成本 | 332,902,222.38 | 162,522,076.05 | 727,278,014.63 | 537,280,995.36 |
| 税金及附加 | 6,876,318.54 | 2,722,266.9 | 10,832,243.03 | 8,056,439.05 |
| 销售费用 | 4,972,994.5 | 3,463,916.8 | 8,216,008.66 | 7,388,848.39 |
| 管理费用 | 46,455,264.53 | 22,289,354.89 | 102,837,760.3 | 74,600,621.78 |
| 研发费用 | 3,471,611.49 | 1,758,051.59 | 3,107,295.68 | 567,677.09 |
| 财务费用 | 38,030.11 | -3,742.76 | 597,542.77 | 605,493.48 |
| 其中:利息费用 | 2,059,760.47 | 673,295.44 | 3,815,098.77 | 2,138,764.09 |
| 其中:利息收入 | 2,612,651.7 | 1,324,854.67 | 4,380,488.88 | 3,074,751.36 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 1,025,434.25 | 511,845.21 | 4,772,921.17 | 4,211,272.7 |
| 加:投资收益 | 535,968.55 | -1,193,171.19 | 32,155,570.61 | 29,505,473.85 |
| 资产处置收益 | 25,803.11 | - | 15,644.3 | 13,836.71 |
| 资产减值损失(新) | 0 | -150,357.54 | -1,152,889.59 | - |
| 信用减值损失(新) | 1,695,658.64 | 673,656.39 | 3,956,832.11 | 2,632,710.47 |
| 其他收益 | 266,447.5 | 168,534.3 | 1,300,779.12 | 1,592,687.35 |
| 四、营业利润 | -53,403,868 | -26,078,176.47 | -30,568,962.67 | 6,951,119.78 |
| 加:营业外收入 | 665,512.38 | 5,438.05 | 15,618,668.86 | 1,612,320.36 |
| 减:营业外支出 | 1,730,973.38 | 414,904.02 | 13,934,375.82 | 3,578,207.03 |
| 五、利润总额 | -54,469,329 | -26,487,642.44 | -28,884,669.63 | 4,985,233.11 |
| 减:所得税费用 | 228,915.55 | -134,803.72 | 7,370,635.43 | 316,843.36 |
| 六、净利润 | -54,698,244.55 | -26,352,838.72 | -36,255,305.06 | 4,668,389.75 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -54,698,244.55 | -26,352,838.72 | -36,255,305.06 | 4,668,389.75 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -52,830,895.3 | -25,149,687.78 | -34,854,476.42 | 4,724,431.93 |
| 少数股东损益 | -1,867,349.25 | -1,203,150.94 | -1,400,828.64 | -56,042.18 |
| 扣除非经常损益后的净利润 | -55,946,948.73 | -25,287,432.04 | -79,028,820.06 | -29,469,828.6 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.12 | -0.06 | -0.08 | 0.01 |
| (二)稀释每股收益 | -0.12 | -0.06 | -0.08 | 0.01 |
| 九、综合收益总额 | -54,698,244.55 | -26,352,838.72 | -36,255,305.06 | 4,668,389.75 |
| 归属于母公司股东的综合收益总额 | -52,830,895.3 | -25,149,687.78 | -34,854,476.42 | 4,724,431.93 |
| 归属于少数股东的综合收益总额 | -1,867,349.25 | -1,203,150.94 | -1,400,828.64 | -56,042.18 |
| 公告日期 | 2026-08-15 | 2026-04-30 | 2026-04-25 | 2025-10-25 |
| 审计意见(境内) | | | 标准无保留意见 | |